Stockreport

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Aethlon Medical, Inc.  (AEMD) 
NASDAQ:AMEX Investor Relations: ir.aethlonmedical.com
PDF Aethlon Medical Granted Full Ethics Approval from the Medanta Institutional Ethics Committee for a Safety, Feasibility, and Dose Finding Study of its Hemopurifier® in Ca [Read more]